A novel pathway links telomeres to NK-cell activity: Implications for immunotherapy

Julien Cherfils-Vicini, Pasquale Zizza, Eric Gilson, Annamaria Biroccio

Research output: Contribution to journalArticle

Abstract

Here, we describe a model in which telomeric repeat-binding factor 2 (TERF2) can control tumorigenesis not only via cancer cell-intrinsic mechanisms but also via non-cancer cell autonomous pathways. Indeed, we have recently shown that TERF2 regulates tissue homeostasis as it promotes the elimination of aged, damaged, and neoplastic cells by the immune system, opening the way to new therapeutic options against cancer.

Original languageEnglish
Article numbere27358
JournalOncoImmunology
Volume3
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Telomere
Natural Killer Cells
Immunotherapy
Immune System
Neoplasms
Carcinogenesis
Homeostasis
Therapeutics

Keywords

  • Immunosurveillance
  • NK cells
  • Telomeres
  • TERF2
  • Tumorigenesis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Oncology
  • Immunology

Cite this

A novel pathway links telomeres to NK-cell activity : Implications for immunotherapy. / Cherfils-Vicini, Julien; Zizza, Pasquale; Gilson, Eric; Biroccio, Annamaria.

In: OncoImmunology, Vol. 3, No. 1, e27358, 2014.

Research output: Contribution to journalArticle

Cherfils-Vicini, Julien ; Zizza, Pasquale ; Gilson, Eric ; Biroccio, Annamaria. / A novel pathway links telomeres to NK-cell activity : Implications for immunotherapy. In: OncoImmunology. 2014 ; Vol. 3, No. 1.
@article{3674ca2b79cf46cd9f7d85050674c83d,
title = "A novel pathway links telomeres to NK-cell activity: Implications for immunotherapy",
abstract = "Here, we describe a model in which telomeric repeat-binding factor 2 (TERF2) can control tumorigenesis not only via cancer cell-intrinsic mechanisms but also via non-cancer cell autonomous pathways. Indeed, we have recently shown that TERF2 regulates tissue homeostasis as it promotes the elimination of aged, damaged, and neoplastic cells by the immune system, opening the way to new therapeutic options against cancer.",
keywords = "Immunosurveillance, NK cells, Telomeres, TERF2, Tumorigenesis",
author = "Julien Cherfils-Vicini and Pasquale Zizza and Eric Gilson and Annamaria Biroccio",
year = "2014",
doi = "10.4161/onci.27358",
language = "English",
volume = "3",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "Taylor and Francis Inc.",
number = "1",

}

TY - JOUR

T1 - A novel pathway links telomeres to NK-cell activity

T2 - Implications for immunotherapy

AU - Cherfils-Vicini, Julien

AU - Zizza, Pasquale

AU - Gilson, Eric

AU - Biroccio, Annamaria

PY - 2014

Y1 - 2014

N2 - Here, we describe a model in which telomeric repeat-binding factor 2 (TERF2) can control tumorigenesis not only via cancer cell-intrinsic mechanisms but also via non-cancer cell autonomous pathways. Indeed, we have recently shown that TERF2 regulates tissue homeostasis as it promotes the elimination of aged, damaged, and neoplastic cells by the immune system, opening the way to new therapeutic options against cancer.

AB - Here, we describe a model in which telomeric repeat-binding factor 2 (TERF2) can control tumorigenesis not only via cancer cell-intrinsic mechanisms but also via non-cancer cell autonomous pathways. Indeed, we have recently shown that TERF2 regulates tissue homeostasis as it promotes the elimination of aged, damaged, and neoplastic cells by the immune system, opening the way to new therapeutic options against cancer.

KW - Immunosurveillance

KW - NK cells

KW - Telomeres

KW - TERF2

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=84899084942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899084942&partnerID=8YFLogxK

U2 - 10.4161/onci.27358

DO - 10.4161/onci.27358

M3 - Article

AN - SCOPUS:84899084942

VL - 3

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 1

M1 - e27358

ER -